Administration of Pomc promoter agonists, such as CRH (routinely administered in the patients with Cushing’s disease of POMC deficiency)78 or melanocortin receptor agonists into the spinal cord may be one of the possibilities to enhance the ß-endorphin level in the PNS. This evidence concerns the gene CRH and obesity due to pro-opiomelanocortin deficiency.